Shares in Norwegian biotechnology company Hofseth Biocare (HBC) closed 10 percent higher on the Oslo Stock Exchange in Wednesday trading following a maiden order from US-based health supplement company Garden of Life.
Owned by the food and beverage giant Nestle, Garden of Life placed the order jointly with Hofseth and European Biotech.
Garden of Life announced it is planning to launch its new salmon-based protein product on the North American market in the third quarter of this year.
